Clinical Trials Directory

Trials / Completed

CompletedNCT03072745

Insomnia and Cognitive Performance in Chronic Pain

Distinct Effect of Insomnia on Cognitive Performance in Individuals With Complex Chronic Pain

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
22 (actual)
Sponsor
Uppsala University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The aim of the present study is to examine cognitive function in a patient population with complex chronic pain to test the hypothesis that insomnia severity on its own predicts objective cognitive function, and that a correlation is not better explained by comorbid depression or anxiety, morphine equivalent daily dose, or the level of pain itself.

Detailed description

Almost 20 % of the adult European population suffers from chronic pain of moderate to severe intensity, and clinical insomnia has been reported in 53-73% of chronic pain patients. Insomnia seems to be correlated with small to moderate impairments in several cognitive functions involved in working and episodic memory and in attention tasks, and chronic pain has been shown to be associated with objective deficits in memory and executive functioning. The aim of the present study is to examine cognitive function in a patient population with complex chronic pain to test the hypothesis that insomnia severity on its own predicts objective cognitive function, and that a correlation is not better explained by comorbid depression or anxiety, morphine equivalent daily dose, or the level of pain itself. Inividuals with complex chronic pain are assessed with a neuropsychological test battery examining different aspects of memory and executive functioning: The Digit Span subtest from Wechsler's Adult Intelligence Scale III (WAIS-III): Verbal working memory. Claeson-Dahl Inventory of Learning and Memory (CD): Verbal retention. The Rey Complex Figure Test (RCFT): Visuospatial retention. The Wisconsin Card Sorting Test (WCST): Cognitive flexibility. The Trail-Making Test (TMT): Sustained attention. The presence of insomnia is examined with the Bergen Insomnia Scale (BIS) , and insomnia severity with the Insomnia Severity Index (ISI). Present pain level at the time of the neuropsychological assessment is quantified using the Visual Analogue Scale (VAS). Pain medication is transformed to the morphine equivalent daily dose (MEDD). Anxiety and depression are assessed with the Hospital Anxiety and Depression Scale.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTNeuropsychological assessmentAssessment with a neuropsychological test battery examining different aspects of memory and executive functioning

Timeline

Start date
2011-01-01
Primary completion
2012-05-01
Completion
2012-06-01
First posted
2017-03-07
Last updated
2017-03-07

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT03072745. Inclusion in this directory is not an endorsement.